(Q45934334)
Statements
[Interferon alpha and half-dose sorafenib is an effective treatment modality for interferon alpha-resistant metastatic renal cell carcinoma: a case report] (English)
Nobutaka Furuya
Takao Kamai
Noriko Tokui
Hideyuki Abe
Yoshitatsu Fukabori
Ken-ichiro Yoshida